Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-022785
Filing Date
2017-03-24
Accepted
2017-03-24 16:59:41
Documents
1
Period of Report
2017-03-21

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3113
  Complete submission text file 0001209191-17-022785.txt   4429
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Issuer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2525 WEST END AVENUE, SUITE 950 NASHVILLE TN 37203
Business Address
Krogulski Kenneth (Reporting) CIK: 0001695580 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33637 | Film No.: 17713359